Introduction
Classically performed DHBS is based on the pharmacokinetics of -Hydroxy Iminodiacetic Acid (HIDA) and similar derivatives of IDA [1] . After IV administration, 99m Tc-HIDA is rapidly accumulated in the liver and after a short intrahepatic transit time, the RF is excreted (the same as the molecular complexes with molecular mass higher than 300) through the biliary system into the duodenum [1] . About
85-90% of 99m
Tc-HIDA is eliminated through the liver, the percentage depending on the status of hepatocyte function [2] .
Scintigraphic images are recorded for 45-60 min, 1 image for each 2 minutes, the recording starting simultaneously with IV injection of RF [1] .
The liver is visualized with 99m Tc-HIDA in normal cases within 0-5 min after IV injection, the common biliary duct -within 5-20 min, gallbladder -within 10-40 min, duodenum -within 15-45 min, and the kidneys -within 0-5 min [2].
In the past few years, the Romanian market of RF products was limited due to economic reasons and legislative gaps.
In this context, IDA derivatives have not been available for DHBS investigations for more than 5 years. This study is a result of our efforts to maximally use the potential of the pharmaceuticals which are still available, in order to perform certain investigations which otherwise would not be possible.
Cecilia Diana E. Pîglesan Tc-TF for MPS has its inconveniences. However, it challenged us to test the possible assessment of the biliary tree using TF.
In our desire to perform DHBS using TF, we also referred to the studies aimed at increasing the quality of MPS by accelerating the biological clearance of 99m Tc-TF through the hepatic bile tree using a high fat lunch, milk, lemon juice, etc [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [16] [17] [18] .
Hepatic tumours and impairment of bile drainage were only incidentally reported when performing MPS with TF [11-13, 19, 20] .
Material and methods

Radiopharmaceutical
TF (Myoview) is a pharmaceutical commonly used for myocardial perfusion studies after radioactive marking with 
Tc.
Its active substance is sodium TF [6,9-bis(2-ethoxyethyl)-3,12-dioxa-6,9-diphosphatetradecane], C 18 H 40 O 4 P 2 , in a concentration of 0.23 mg/bottle [3] . The product is created for IV administration to patients after reconstitution is obtained by adding sodium pertechnetate (Na TF is captured during the first passage by the myocardium cells, with an extraction rate of about 40%. The tracer remaining in circulation is extracted mostly by the hepatic parenchyma (at the level of hepatocytes) and afterwards it is evacuated it follows the bile tree (being a lipophilic complex with molecular mass 895), with less than 15% being eliminated through the kidneys [3, 4, 22] . In our study the right kidney image has shown to be an inconvenient due to its.
The time of appearance of TF in different parts of the bile tree has not been standardized yet. Because the common bile duct area is usually placed over the right kidney region, recording the dynamic parameters for the common bile duct is of less importance than identification of stasis.
Patient characteristics
We examined a total of 30 patients aged 58.4 ± 11.2 years, 8 men and 22 women.
Fourteen patients were normal controls aged 38.5 ± 9.5 years, investigated in order to establish the basic aspect of the investigation. Ten of them were referred to our department for MPS without having liver or biliary illness.
Scintigraphy protocol
The patients were fasted for 12 hours before the examination so as not to influence the biological clearance of Tc-TF. The cases were referred for investigation by the internal medicine and surgery departments of our hospital. We were not involved in the selection.
The investigations were performed with a SPECT Orbiter Siemens gamma-camera equipped with a low-energy, high-resolution, parallel collimator. The acquisition and processing of data were performed using a Power MacIntosh computer connected to the gamma-camera, using the ICON programs designed for scintigraphy investigations.
In order to perform DHBS, we respected the preparation procedure of The radioactive marking of the pharmaceutical product, acquisition of data, and compliance of radiological security conditions were performed by the laboratory's physicist. The interpretation of images was made by our department's medical doctor.
Radiation dosimetry
In order to introduce into use a new investigation based on a radiopharmaceutical already approved for another type of scintigraphy, it is absolutely necessary to respect the radioprotection of patients and medical personal according to ALARA (As Low
As Reasonably Achievable) principles.
Because 99m Tc-TF is a radiotracer widely used for MPS, its dosimetry is standardized for the higher doses used in MPS [3] . The gallbladder walls absorb the highest doses, followed by the intestine [3] .
Because the doses which we used at DHBS were [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] times smaller than at MPS, internal irradiation is also lower than during MPS, which had already been shown as respecting ALARA principles. This fact justifies the use of TF for DHBS in a radioprotection point of view, in addition to the favourable ratio between irradiation and diagnosis benefit.
Results
Comparing the scintigraphy images at DHBS using 99m Tc-TF with those which we have in our laboratory database, obtained 
Normal aspect
In normal patients, maximum amplitude of liver curve occurred The gallbladder was visualized starting with 28 ± 7 min after the injection. Table I For 2 of these, the gallbladder also did not appear on static images recorded at 1.5 h, 2 h, and 3 h, while for 4 of them the gall bladder could only be visualized on static images at 2 h and 3 h (Figures 1, 2) . Clinical diagnosis of acute cholecystitis was excluded for those patients.
Pathological aspects
One patient had important stasis on the biliary confluent area and partly in the left lobe bile duct.
For two patients the tracer arrived to the gallbladder in due time, but its excretion in the duodenum at 45 minutes and 1 h post-injection was very small, although no stasis or obstacle was found One patient had an incomplete obstacle at the level of the junction of the cystic duct with the common biliary duct. ERCP confirmed this diagnosis (Figure 3 ).
We also investigated two post-surgery patients suspected of having fistulas: one of them with bilio-intestinal fistula (Figure 4) and the other with bilio-bronchial fistula. For the both of them, DHBS highlighted RF stasis at the origin point of the fistula and pathological dynamic of RF determined by the fistula. The thin trajectory of fistulas could not be visualized.
Another case was of a 52-year-old woman who had a defective uptake of tracer in the hilum area liver scintigraphy with radiocolloid. DHBS detected a dilation of intrahepatic biliary tree with important stasis in the biliary confluent area ( Figure 5 ).
For a patient diagnosed clinically with common bile duct obstructed by a bile stone, DHBS showed a dilated common bile duct, most probably due to an incomplete obstacle at the level of the Oddi sphincter. This diagnosis was confirmed by ERCP.
The dynamic liver aspect for an asymptomatic patient is shown in Figure 6 . The liver curve reaches its highest amplitude at 10 min post-injection. Half of the liver curve amplitude calculated were not able to answer requests for DHBS, leaving us compelled to find a solution to be able to again perform such investigations.
Use of TF as RF for DHBS has been based on its pharmacokinetics involving excretion through the liver and biliary tree.
After introducing
99m Tc-TF in the practice of our laboratory (for MPS and parathyroid scintigraphy) we have been able to verify the good resolution of images of the liver and biliary tree area during these standard investigations.
The bibliography includes several studies related to the opportunity to influence the time of evacuation from the liver of 99m Tc-TF at MPS using different types of foods [5] [6] [7] [8] [9] [10] [11] [16] [17] [18] .
We found information about several cases of liver or biliary pathology incidentally reported at MPS [11-13, 19, 20] . Some later studies used TF to determine ejection fraction of the gallbladders of patients referred for MPS [21] . Because the tracer 99m Tc-TF is the first-choice for MPS and it is currently used for this investigation, performing DHBS by using residual tracer from MPS has great advantages in an economical point of view.
Due to the fact that the RF used does not contain iodine,
DHBS with 99m
Tc-TF may be performed in allergic patients in whom iodine-based radiological contrast agents cannot be used.
From a radioprotection point of view, use of TF for DHBS respects irradiation limits.
We were therefore able to be of help with scintigraphy diagnosis for various dyskinesia cases, biliary fistulas, biliary stasis, and common bile duct stenosis.
Conclusions
Biliary drainage of 99m
Tc-TF allows the acquisition of good quality images of the intra-hepatic bile tree, common bile duct, and gallbladder. The good resolution of images allows identification of intra-and extrahepatic stasis areas, as well as the dynamics of tracer at their level.
The tracer quantity evacuated in the bile tree is enough to allow rising dynamic curves with good resolution. The dynamics of 99m Tc-TF allows late visualization of bile tracts, up to 3 hours after the injection.
